- AmpliPhi Biosciences (NYSEMKT:APHB): Q1 GAAP EPS of -$0.11 in-line.
- More news on: AmpliPhi Biosciences Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
AmpliPhi Biosciences Corporation Company Name:
APHB Stock Symbol:
Market:
AmpliPhi Biosciences Corporation (NYSE American: APHB) , a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that its stockholders voted to approve the proposals required to complete the busines...
Entered into a merger agreement with C3J Therapeutics that is expected to result in an NYSE American-listed company (to be named Armata Pharmaceuticals) focused on development of precisely targeted bacteriophage therapeutics $10.0 million of new capital to be invested in combined co...
Entered into a merger agreement with C3J Therapeutics that is expected to result in an NYSE American-listed company focused on development of precisely-targeted bacteriophage therapeutics $10.0 million of new capital will be invested in combined company to be re-named Armata Pharmac...